- Home
- SABS vs REBN Comparison
SABS vs REBN Comparison
Compare SABS & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- REBN
- Stock Information
- Founded
- SABS 2014
- REBN 2015
- Country
- SABS United States
- REBN United States
- Employees
- SABS N/A
- REBN N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- REBN Restaurants
- Sector
- SABS Health Care
- REBN Consumer Discretionary
- Exchange
- SABS Nasdaq
- REBN Nasdaq
- Market Cap
- SABS 15.8M
- REBN 13.5M
- IPO Year
- SABS N/A
- REBN 2022
- Fundamental
- Price
- SABS $1.76
- REBN $2.36
- Analyst Decision
- SABS Strong Buy
- REBN
- Analyst Count
- SABS 5
- REBN 0
- Target Price
- SABS $11.80
- REBN N/A
- AVG Volume (30 Days)
- SABS 33.1K
- REBN 48.2K
- Earning Date
- SABS 08-07-2025
- REBN 08-18-2025
- Dividend Yield
- SABS N/A
- REBN N/A
- EPS Growth
- SABS N/A
- REBN N/A
- EPS
- SABS N/A
- REBN N/A
- Revenue
- SABS $377,835.00
- REBN $6,103,732.00
- Revenue This Year
- SABS N/A
- REBN $335.98
- Revenue Next Year
- SABS N/A
- REBN N/A
- P/E Ratio
- SABS N/A
- REBN N/A
- Revenue Growth
- SABS N/A
- REBN 3.38
- 52 Week Low
- SABS $1.00
- REBN $1.03
- 52 Week High
- SABS $5.01
- REBN $8.30
- Technical
- Relative Strength Index (RSI)
- SABS 47.99
- REBN 36.68
- Support Level
- SABS $1.60
- REBN $2.40
- Resistance Level
- SABS $1.80
- REBN $2.65
- Average True Range (ATR)
- SABS 0.12
- REBN 0.14
- MACD
- SABS -0.02
- REBN -0.00
- Stochastic Oscillator
- SABS 50.00
- REBN 12.05
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.